Read + Share
Powles T, Petrylak DP, Rosenberg JE. Beyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of
the Novel Therapies for Metastatic Urothelial Carcinoma. J Clin Oncol 2021;39:3411-3412.
PMID: 34491780
|
 |
|
Powles T, Petrylak DP, Rosenberg JE. Beyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of
the Novel Therapies for Metastatic Urothelial Carcinoma. J Clin Oncol 2021;39:3411-3412.
PMID: 34491780
|
|
|
|